Judy Lewent - Thermo Fisher Independent Director

TMO Stock  USD 529.63  7.97  1.53%   

Director

Ms. Judy C. Lewent is Independent Director of the Company. She was Chief Financial Officer of Merck Co., Inc., a global pharmaceutical company, from 1990 until her retirement in 2007. She was also Executive Vice President of Merck from February 2001 through her retirement and had additional responsibilities as President, Human Health Asia from January 2003 until July 2005, when she assumed strategic planning responsibilities for Merck since 2008.
Age 71
Tenure 16 years
Address 168 Third Avenue, Waltham, MA, United States, 02451
Phone781 622 1000
Webhttps://www.thermofisher.com
Lewent is also a director of Motorola Solutions, Inc. and GlaxoSmithKline plc. We believe that Ms. Lewent is well suited to serve on our Board due to her many years of global experience in finance and the pharmaceutical industry.

Thermo Fisher Management Efficiency

The company has Return on Asset of 0.0467 % which means that on every $100 spent on assets, it made $0.0467 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1294 %, implying that it generated $0.1294 on every 100 dollars invested. Thermo Fisher's management efficiency ratios could be used to measure how well Thermo Fisher manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of December 2024, Return On Tangible Assets is likely to drop to 0.09. In addition to that, Return On Capital Employed is likely to drop to 0.05. At this time, Thermo Fisher's Other Assets are very stable compared to the past year. As of the 1st of December 2024, Fixed Asset Turnover is likely to grow to 4.79, while Net Tangible Assets are likely to drop (13.7 B).
Thermo Fisher Scientific has 34.92 B in debt with debt to equity (D/E) ratio of 0.67, which is OK given its current industry classification. Thermo Fisher Scientific has a current ratio of 1.71, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Thermo to invest in growth at high rates of return.

Similar Executives

Showing other executives

DIRECTOR Age

Edward ConardWaters
63
Raymond StevensDanaher
57
Sue RatajAgilent Technologies
63
Gary HendricksonWaters
64
Thomas SaliceMettler Toledo International
61
WahHui ChuMettler Toledo International
69
Elisha FinneyMettler Toledo International
59
Richard WallmanCharles River Laboratories
69
Deborah KochevarCharles River Laboratories
64
Teri ListStollDanaher
58
Virginia WilsonCharles River Laboratories
66
Paul ClarkAgilent Technologies
72
Daniel PodolskyAgilent Technologies
67
Laurie GlimcherWaters
66
Michael BerendtWaters
71
Francis deSouzaIllumina
53
A SandersDanaher
58
Martin MackayCharles River Laboratories
65
Heidi KunzAgilent Technologies
66
Alan SpoonDanaher
69
Caspar TudorWaters
N/A
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company was incorporated in 1956 and is based in Waltham, Massachusetts. Thermo Fisher operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 130000 people. Thermo Fisher Scientific (TMO) is traded on New York Stock Exchange in USA. It is located in 168 Third Avenue, Waltham, MA, United States, 02451 and employs 122,000 people. Thermo Fisher is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

Thermo Fisher Scientific Leadership Team

Elected by the shareholders, the Thermo Fisher's board of directors comprises two types of representatives: Thermo Fisher inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Thermo. The board's role is to monitor Thermo Fisher's management team and ensure that shareholders' interests are well served. Thermo Fisher's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Thermo Fisher's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jim Manzi, Independent Chairman of the Board
Michel Lagarde, Senior Vice President and President, Pharma Services
Mark Stevenson, Executive VP and President of Life Sciences Solutions
Rafael Tejada, Vice Relations
Stephen Williamson, Chief Financial Officer, Senior Vice President
Tyler Jacks, Independent Director
James Mullen, Independent Director
Dion Weisler, Independent Director
Karen Nelson, Chief Officer
Debora Spar, Independent Director
Peter Hornstra, Vice President Chief Accounting Officer
Judy Lewent, Independent Director
Michael Boxer, Senior Vice President General Counsel
Ruby Chandy, Director
Joseph Holmes, Chief Accounting Officer, Vice President
Lars Sorensen, Independent Director
C Harris, Independent Director
Elaine Ullian, Independent Director
Thomas Lynch, Director, Chairman of Nominating and Corporate Governance Committee and Member of Compensation Committee
Ryan Snyder, Senior Officer
Nelson Chai, Independent Director
Lisa Britt, Chief VP
Syed Jafry, Senior Vice President and President Regions
Marc Casper, CEO and President Director, Member of Strategy and Fin. Committee and Member of Science and Technology Committee
Michael Esq, Senior Counsel
Sandy Pound, VP Officer
Scott Sperling, Independent Director
R Keith, Independent Director
Gianluca Pettiti, Senior Vice President and Presidentident - Specialty Diagnostics business

Thermo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Thermo Fisher a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Thermo Fisher

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thermo Fisher position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thermo Fisher will appreciate offsetting losses from the drop in the long position's value.

Moving together with Thermo Stock

  0.73A Agilent Technologies Sell-off TrendPairCorr
  0.92ME 23Andme Holding Upward RallyPairCorr
  0.81VALN Valneva SE ADRPairCorr

Moving against Thermo Stock

  0.79VCYT VeracytePairCorr
  0.77DRUG Bright Minds Biosciences TrendingPairCorr
  0.7VCEL Vericel Corp OrdPairCorr
  0.7VERA Vera TherapeuticsPairCorr
  0.66VANI Vivani MedicalPairCorr
The ability to find closely correlated positions to Thermo Fisher could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thermo Fisher when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thermo Fisher - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thermo Fisher Scientific to buy it.
The correlation of Thermo Fisher is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thermo Fisher moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thermo Fisher Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thermo Fisher can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.04)
Dividend Share
1.52
Earnings Share
15.94
Revenue Per Share
110.627
Quarterly Revenue Growth
0.002
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.